Invention Grant
- Patent Title: Mixed ligand gold(I) complexes as anti-cancer agents
-
Application No.: US15351585Application Date: 2016-11-15
-
Publication No.: US10077280B2Publication Date: 2018-09-18
- Inventor: Said S. Al-Jaroudi , Ali Alhoshani , Muhammad Altaf , Anvarhusein Abdulkadir Isab
- Applicant: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS , KING SAUD UNIVERSITY
- Applicant Address: SA Dhahran SA Riyadh
- Assignee: King Fahd University of Petroleum and Minerals,King Saud University
- Current Assignee: King Fahd University of Petroleum and Minerals,King Saud University
- Current Assignee Address: SA Dhahran SA Riyadh
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Main IPC: A61K31/66
- IPC: A61K31/66 ; C07F9/50 ; A61K45/06 ; G01N33/574 ; C12Q1/68 ; A61K9/00 ; C12Q1/6886
Abstract:
Gold(I) complex with mixed ligands as an anticancer agent. The gold(I) ion is coordinated to a dithiocarbamate ligand and a phosphorus-containing ligand (e.g. phosphines). Also described are a pharmaceutical composition incorporating the gold(I) complex, a methods of synthesizing the gold(I) complex, and a method for treating cancer.
Public/Granted literature
- US20170305942A1 MIXED LIGAND GOLD(I) COMPLEXES AS ANTI-CANCER AGENTS Public/Granted day:2017-10-26
Information query
